On-Demand Webinar

D360 as your organization’s extendable and central data engine

D360 is an industry-leading scientific data informatics platform providing a flexible, scalable, and customizable enterprise…

Certara2023 年 1 月 20 日

On-Demand Webinar

Physiologically-Based Pharmacokinetic Modeling & Simulation to Support Asciminib NDA Submission & Inform Drug Product Label

Physiologically based pharmacokinetic (PBPK) modeling and simulation has become an established approach to assess drug-drug…

Certara2023 年 1 月 13 日

Announcement

Certara Awarded NIH Contract for Toxicology Consulting Support

Certara toxicology experts to support NIH’s BPN and HEAL drug development programs for nervous system…

Certara2023 年 1 月 10 日

视频

如果您研发的药物是 CYP3A 底物，我们有好消息要告诉您！

Certara2023 年 1 月 9 日

Announcement

Ghent University wins the 2021/22 Certara-Simcyp Grant and Partnership Scheme

PRINCETON, N.J., 2023 年 1 月 9 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation,…

Certara2023 年 1 月 9 日

White Paper

Drug interactions with therapeutic proteins, regulatory expectations and modeling and simulation approaches

Certara2023 年 1 月 3 日

Blog

New FDA requirement to support labeling on DDIs in the pediatric population

The effects of drug-drug interactions (DDIs) could differ in the pediatric population compared to adults.…

Certara2022 年 12 月 21 日

Blog

The Phoenix workflow shortcuts every pharmacokineticist needs

Certara’s Phoenix™ Pharmacokinetic and Pharmacodynamic (PK/PD) Platform can revolutionize your pharmaceutical organization’s approach to PK/PD…

Certara2022 年 12 月 16 日

Press Release

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private Equity…

Certara2022 年 12 月 8 日

On-Demand Webinar

治疗蛋白质的药物间相互作用：最新情况与挑战

Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…

Certara2022 年 12 月 5 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

pre-update

D360 as your organization’s extendable and central data engine

Physiologically-Based Pharmacokinetic Modeling & Simulation to Support Asciminib NDA Submission & Inform Drug Product Label

Certara Awarded NIH Contract for Toxicology Consulting Support

如果您研发的药物是 CYP3A 底物，我们有好消息要告诉您！

Ghent University wins the 2021/22 Certara-Simcyp Grant and Partnership Scheme

Drug interactions with therapeutic proteins, regulatory expectations and modeling and simulation approaches

New FDA requirement to support labeling on DDIs in the pediatric population

The Phoenix workflow shortcuts every pharmacokineticist needs

Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors

治疗蛋白质的药物间相互作用：最新情况与挑战

订阅时事通讯

快捷链接

解决方案

联系我们